Cargando…
554. Does Protease Inhibitor (PI) Monotherapy Select Primary PI Resistance?
BACKGROUND: Combination drug therapy is the standard of care for HIV treatment. PI monotherapy is considered experimental in the United States. However, some patients end up receiving PI monotherapy secondary to resistance and/or drug intolerance to other antiretroviral (cART) classes. This study wi...
Autores principales: | Saling, Christopher, Atallah, Liana, Haddad, Tyler, Learned, Brooke, Slim, Jihad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253806/ http://dx.doi.org/10.1093/ofid/ofy210.562 |
Ejemplares similares
-
Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037
por: Haagensen, Emma J., et al.
Publicado: (2016) -
63. Prognosis of COVID-19 Patients with Diabetic Ketoacidosis with or Without Hyperosmolar Hyperglycemic State
por: Chan, Kok Hoe, et al.
Publicado: (2020) -
552. Could Anticoagulant Use Prior to Infection with COVID-19 Decrease Mortality?
por: Natali, Kayla M, et al.
Publicado: (2020) -
361. A Case Control Study of COVID-19 Outcome in Patients with HIV
por: Atallah, Liana, et al.
Publicado: (2020) -
554. Discharge Antibiotic Prescribing at Children’s Hospitals with Established Antimicrobial Stewardship Programs
por: Same, Rebecca, et al.
Publicado: (2022)